Amneal Pharmaceuticals, Inc.

AMRX · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$110,552$91,542$25,976$247,790
Short-Term Investments$1,868$2,200$1,821$0
Receivables$775,731$645,660$741,791$694,740
Inventory$612,454$581,384$530,735$489,389
Other Curr. Assets$87,201$57,077$111,495$88,189
Total Curr. Assets$1,587,806$1,377,863$1,411,818$1,520,108
Property Plant & Equip (Net)$523,693$550,137$589,360$639,003
Goodwill$597,436$598,629$598,853$593,017
Intangibles$732,377$890,423$1,096,093$1,166,922
Long-Term Investments$35,921$37,089$85,586$0
Tax Assets$0$0$0$0
Other NC Assets$24,212$18,428$17,631$20,614
Total NC Assets$1,913,639$2,094,706$2,387,523$2,419,556
Other Assets$0$0$0$0
Total Assets$3,501,445$3,472,569$3,799,341$3,939,664
Liabilities
Payables$259,844$143,572$166,843$131,084
Short-Term Debt$340,255$227,624$104,639$46,037
Tax Payable$0$0$0$2,523
Deferred Revenue$0$398,411$0$0
Other Curr. Liab.$529,672$76,988$481,318$497,599
Total Curr. Liab.$1,129,771$846,595$752,800$677,243
LT Debt$2,252,884$2,522,899$2,740,496$2,830,019
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$163,328$41,771$97,117$65,429
Total NC Liab.$2,416,212$2,564,670$2,837,613$2,895,448
Other Liabilities$0$0$0$0
Cap. Leases$107,136$109,947$123,487$127,351
Total Liabilities$3,545,983$3,411,265$3,590,413$3,572,691
Equity
Pref Stock$0$0$0$0
Common Stock$3,099$3,066$3,036$3,014
Retained Earnings-$607,062-$490,176-$406,183-$276,197
AOCI-$65,510-$32,349$9,939-$24,827
Other Equity$560,206$539,240$691,629$658,350
Total Equity-$109,267$19,781$298,421$360,340
Supplemental Information
Minority Interest$64,729$41,523-$89,493$6,633
Total Liab. & Tot. Equity$3,501,445$3,472,569$3,799,341$3,939,664
Net Debt$2,482,587$2,658,981$2,819,159$2,628,266
Amneal Pharmaceuticals, Inc. (AMRX) Financial Statements & Key Stats | AlphaPilot